[Estimation of clinical reliability and diagnostic usefulness of human fatty acid-binding protein in acute coronary syndromes].
Human fatty acid-binding protein (h-FABP) is an early marker of myocardial ischemia. It has high sensitivity and specificity comparing with conventional biomarkers such as troponin or creatine kinase. The examinated group consisted of 83 patients, 31 (37,3%) women and 52 (62,7%) men. Every patient with chest pain typical for acute coronary syndrome was diagnosed from May until September 2005 in the emergency room of the Clinic of Cardiology. Every blood sample was tested for h-FABP with Cardio Detect med. test. Sensitivity for h-FABP at STEMI patients was: during first 3h - 95, 83%, 3-6h - 100%, 6-12h - 100%, over 12h - 100%. Sensitivity for h-FABP at NSTEMI patients was: 100%, 100%, 83% and 71,4%. H-FABP is an early diagnostic marker. Its sensitivity and specificity during first 6h from the beginning of chest pain comparing to troponin T and CK-MB is very high. Fast results given by measurements of h-FABP allow to make an early decision about further invasive treatment of patients.